[1]
2024. Cost-effectiveness of budesonide-formoterol in maintenance therapy of asthma patients at Mexico’s National Center for Respiratory Diseases. Revista Alergia México. 71, 4 (Dec. 2024), 218–228. DOI:https://doi.org/10.29262/ram.v71i4.1295.